Category Archives: Policy News
Impact of International Reference Pricing on Drug Innovation
Policymakers in Washington are considering plans to replace the current market-based system for pricing prescription medicines with a system based on foreign reference pricing. If enacted, this policy will import to the US price controls that foreign countries use to deny patients access to the newest cures and treatments. It could also impede innovation and […]
President Biden Signs $1.9 Trillion COVID-19 Relief Bill
Yesterday, President Biden signed into law the American Rescue Plan (H.R. 1319), a $1.9 trillion COVID-19 relief package that Congress approved this week. On Wednesday, the House of Representatives approved the Senate-passed version of the bill by a vote of 220 to 211, with one Democrat joining all Republicans in voting against it. Rep. Jared […]
BioUtah Recognizes Rare Disease Day
Today, BioUtah recognizes Rare Disease Day – its patients, families, healthcare providers, advocates, policymakers and drug manufacturers – all dedicated to making a difference in the fight against rare disease. Here in Utah, we are working closely with our partners in the rare disease community to raise awareness and harness resources to support the goal […]
BioUtah Hosts LIfe Sciences Roundtable with Congressional Healthcare Leaders
BioUtah recently held a life sciences industry roundtable with Republican lawmakers in the U.S. House of Representatives who play a key role in shaping healthcare policy around the FDA, CMS, NIH and more. Lawmakers included our own Rep. John Curtis (R-UT) who now sits on the House Energy and Commerce (E&C) Committee and Subcommittee on […]
Control Medical Technology Announces New Device Removes Large Blood Clots in 1st Deep Vein Thrombosis (DVT) Patient Use
Control Medical Technology today announced the FDA cleared Control 11F Mechanical Thrombectomy system was used to remove large blood clots from patients with deep vein thrombosis (DVT). The system is Utah born, designed, engineered, patent prosecuted, and manufactured. “The Control 11 French Mechanical Thrombectomy System can remove large clots,” said Shawn Fojtik, President of Control […]
President Biden Unveils COVID-19 Vaccine Plan
In an effort to speed up vaccinations after a slower than expected rollout, HHS last week began encouraging states to start vaccinating individuals 65 and older, along with those ages 16 and older with comorbidities. Meanwhile President Biden unveiled a COVID-19 vaccination plan which aims to pick up the pace of vaccinations by creating federal […]
President Biden Unveils COVID-19 Relief Plan
President Biden has unveiled the first part in his two-part plan for rescue and economic recovery—the American Rescue Plan. He is expected to lay out part two – the Build Back Better Recovery Plan, next month. The $1.9 trillion American Rescue Plan is intended to address immediate COVID-19 needs, while the Build Back Better Recovery […]
Day One – Biden Administration Issues Regulatory Freeze
Issuing a regulatory freeze is standard practice for an incoming administration, so as expected, shortly after President Biden was sworn in on January 20, the White House issued a memo directing agencies to freeze for 60 days any agency rules or guidance issued by the Trump administration that have not taken effect by Inauguration Day. […]
President Biden Signs Flurry of Executive Orders on COVID-19, $15 Minimum Wage for Federal Workers, Buy American Next
Following his inauguration on January 20, President Biden signed 17 executive orders — including several aimed at COVID-19 and others overturning a number of President Trump’s previous executive orders and policies. The January 20 orders included a mask mandate for all federal properties and for interstate travel, rejoining the World Health Organization, reinstating the Global […]
Present at BIO-Europe Spring® Digital
Apply to Present at BIO-Europe Spring® Digital NEW deadline to apply is January 20. View Presentation Options Attracting visibility as a presenting company has never been easier at BIO-Europe Spring Digital! While presenting at a digital event may be different than what you are used to in person, it does provide new opportunities for […]
LS & Pharmaceuticals Industry Report
This report offers a high-level overview focused mainly on the pharmaceutical industry, related capital events – incl. investments in biotech and medtech companies – FDI flows, the biggest players in the field, and the key trends in life sciences. Read the full report below: LS & Phamaceuticals Industry Report
BioUtah Joins Patient Groups Opposing MFN
BioUtah joined numerous patient advocates and healthcare providers in sending a letter to U.S. House and Senate leaders in opposition to the Trump administration’s Most-Favored-Nation (MFN) drug pricing rule. The letter, organized by The Part B Access for Seniors and Physicians (ASP) Coalition, stated that the MFN model for Medicare Part B drugs will “lead […]
